Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:39 PM
Ignite Modification Date:
2025-12-24 @ 5:39 PM
NCT ID:
NCT06106568
Eligibility Criteria:
Inclusion Criteria:
* Patients having at least one confirmed diagnosis of pancreatic cancer (identified by ICD-10 diagnosis code C25.x, without a suspicious diagnosis flag) during the patient selection period
* Patients having at least one active treatment record after the 1st confirmed diagnosis of pancreatic cancer
* Patients 18 years of age or older at the index date
* Patients having any recorded CE-CT or EOB-MRI or MRI without EOB record during the baseline period
* EOB-MRI stands for enhanced liver MRI using gadoxetate sodium as the contrast agent. In this type of MRI, gadoxetate sodium is used as a contrast agent in the visualization of the liver tumor.
* EOB-MRI group will include patients who underwent EOB-MRI during the baseline period.
* Non-EOB-MRI group will include patients who underwent CE-CT or MRI with contrast agent other than the gadoxetate sodium during the baseline period.
* MRI, CE-CT and contrast agents are identified by using the nine-digit Japanese receipt code specified in the separate code list
Exclusion Criteria:
* Patients with no confirmed diagnosis of pancreatic cancer (ICD-10 diagnosis code C25.x) in the below category of the disease name in the discharge summary until the 1st discharge date after the index date:
* "ICD-10 code of disease name which input the most medical resources"
* "ICD-10 name of disease behind hospitalization"
* Patients with no active treatment within 3 months (90 days) from the con-firmed pancreatic cancer diagnosis date
* Patients with no medical record in the MDV database within 1 month (30 days) from the index date
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06106568
Study Brief:
Protocol Section:
NCT06106568